Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MAP2K1 |
Variant | I103_K104del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | MAP2K1 I103_K104del results in the deletion of two amino acids in the Map2k1 protein from amino acids 103 to 104 (UniProt.org). I103_K104del confers a gain of function to the Map2k1 protein as demonstrated by activity independent of Raf and increased phosphorylation of Mek and Erk relative to wild-type Map2k1 (PMID: 29483135), increased Mek and Erk phosphorylation in culture (PMID: 28935960, PMID: 30377225), increased proliferation in a competition assay, and increased transformation activity in culture (PMID: 36442478). |
Associated Drug Resistance | |
Category Variants Paths |
MAP2K1 mutant MAP2K1 act mut MAP2K1 I103_K104del |
Transcript | NM_002755.4 |
gDNA | chr15:g.66436761_66436766delATCAAA |
cDNA | c.307_312delATCAAA |
Protein | p.I103_K104delIK |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001411065.1 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
XM_017022411 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
XM_017022412 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
XM_017022413 | chr15:g.66485132_66485137delTGGAAG | c.308_313delTGGAAG | p.V103_E104delVE | RefSeq | GRCh38/hg38 |
XM_017022411.2 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
XM_011521783.4 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
XM_017022411.3 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
NM_002755 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
XM_017022413.1 | chr15:g.66485132_66485137delTGGAAG | c.308_313delTGGAAG | p.V103_E104delVE | RefSeq | GRCh38/hg38 |
NM_002755.4 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
NM_002755.3 | chr15:g.66436761_66436766delATCAAA | c.307_312delATCAAA | p.I103_K104delIK | RefSeq | GRCh38/hg38 |
XM_017022412.1 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
XM_011521783.3 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
XM_011521783 | chr15:g.66436827_66436832delTACATC | c.307_312delTACATC | p.Y103_I104delYI | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
MAP2K1 I103_K104del | Advanced Solid Tumor | decreased response | Trametinib | Preclinical - Biochemical | Actionable | In a preclinical study, transformed cells expressing MAP2K1 I103_K104del were less sensitive to Mekinist (trametinib) compared to similar mutations in the negative regulatory domain of the Map2k1 protein in culture (PMID: 32641410). | 32641410 |
MAP2K1 I103_K104del | Advanced Solid Tumor | predicted - sensitive | SCH772984 | Preclinical - Biochemical | Actionable | In a preclinical study, SCH772984 inhibited downstream signaling in transformed cells expressing MAP2K1 I103_K104del in culture (PMID: 32641410). | 32641410 |